Costello Syndrome: The Challenge of Hypoglycemia and Failure to Thrive

Article history: Received 22 November 2017 Accepted 6 December 2017 Available online 7 December 2017 by CS, provided evidence of a new possible mechanism underlying failure to thrive in this condition (Leoni et al., 2016). In the samepatient cohort the Authors detected low glucose and high cholesterol levels in the blood and described normal/high daily caloric intake in the CS cohort compared to the recommended levels of nutrients, excluding low caloric intake as a reason for poor weight gain. In particular a high protein

• Publication year

  2017

• Venue

  EBioMedicine

• Publication date

  2017-12-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ebiom.2017.12.006PMID 29248509PMCID 5828550
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis

  2017cited by this paper
• Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models

  2017cited by this paper
• Understanding Growth Failure in Costello Syndrome: Increased Resting Energy Expenditure.

  2016cited by this paper
• Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations

  2011influential reference
• Endogenous expression of HrasG12V induces developmental defects and neoplasms with copy number imbalances of the oncogene

  2009influential reference
• Germline expression of H‐RasG12V causes neurological deficits associated to Costello syndrome

  2009cited by this paper
• A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition.

  2008influential reference
• Costello syndrome and hyperinsulinemic hypoglycemia

  2005cited by this paper
• Germline mutations in HRAS proto-oncogene cause Costello syndrome

  2005cited by this paper
• Costello syndrome with growth hormone deficiency and hypoglycemia: A new report and review of the endocrine associations

  2004cited by this paper

• RASopathies in Cardiac Disease.

  2024cites this paper
• Prenatal Diagnosis of Costello Syndrome Using Noninvasive Prenatal Single Gene Testing With Maternal Blood

  2023cites this paper
• Multidisciplinary Management of Costello Syndrome: Current Perspectives

  2022cites this paper
• Management of nutritional and gastrointestinal issues in RASopathies: A narrative review

  2022cites this paper
• Hyperactive HRAS dysregulates energetic metabolism in fibroblasts from patients with Costello syndrome via enhanced production of reactive oxidizing species.

  2021cites this paper